Literature DB >> 2555836

Potential use of nonpathogenic enteroviruses for control of human disease.

M K Voroshilova.   

Abstract

Until recently, it has been generally assumed that all human viruses are causative agents of diseases and should be regarded as harmful pathogenic agents that require control measures. In the early 1950s we began to doubt this view. In the course of experiments on virus isolations from feces of normal children, as well as in studies of isolates from animals and from tissue cultures, data accrued which suggested that some conditionally pathogenic and some completely nonpathogenic strains of enteroviruses may provide some benefit to their host by inhibition of pathogenic viruses and by activating nonspecific protective functions of the organism. The novel concept of beneficial viruses was proposed which suggested that the process of co-evolution of the host organism and its associated viral flora led to a specific interaction between them that was beneficial for both. This concept provides a potential approach to the nonspecific prevention of viral diseases by means of the interference between beneficial enteroviruses and pathogenic viruses belonging to different classes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555836

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN: 0079-645X


  18 in total

1.  Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.

Authors:  Benjamin J Cowling; Vicky J Fang; Hiroshi Nishiura; Kwok-Hung Chan; Sophia Ng; Dennis K M Ip; Susan S Chiu; Gabriel M Leung; J S Malik Peiris
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

2.  Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.

Authors:  Peter Aaby; Andreas Andersen; Cesário L Martins; Ane B Fisker; Amabelia Rodrigues; Hilton C Whittle; Christine S Benn
Journal:  BMJ Open       Date:  2016-12-23       Impact factor: 2.692

Review 3.  Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies?

Authors:  Melanie Malave Sanchez; Paul Saleeb; Shyam Kottilil; Poonam Mathur
Journal:  Open Forum Infect Dis       Date:  2021-07-09       Impact factor: 3.835

Review 4.  Viral Interference between Respiratory Viruses.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2022-02       Impact factor: 6.883

5.  Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.

Authors:  Nathaniel Hupert; Daniela Marín-Hernández; Bo Gao; Ricardo Águas; Douglas F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 11.205

6.  Use of oral polio vaccine and the incidence of COVID-19 in the world.

Authors:  Farrokh Habibzadeh; Konstantin Chumakov; Mohammad M Sajadi; Mahboobeh Yadollahie; Kristen Stafford; Ashraf Simi; Shyamasundaran Kottilil; Iman Hafizi-Rastani; Robert C Gallo
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

7.  Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study.

Authors:  Signe Sørup; Lone G Stensballe; Tyra G Krause; Peter Aaby; Christine S Benn; Henrik Ravn
Journal:  Open Forum Infect Dis       Date:  2015-12-17       Impact factor: 3.835

8.  National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials.

Authors:  Andreas Andersen; Ane Baerent Fisker; Amabelia Rodrigues; Cesario Martins; Henrik Ravn; Najaaraq Lund; Sofie Biering-Sørensen; Christine Stabell Benn; Peter Aaby
Journal:  Front Public Health       Date:  2018-02-02

Review 9.  A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID-19 in the United States.

Authors:  Kimberly M Thompson; Dominika A Kalkowska; Kamran Badizadegan
Journal:  Risk Anal       Date:  2020-10-20       Impact factor: 4.000

10.  National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004-2019 demographic surveillance data in rural Bangladesh.

Authors:  Sebastian Nielsen; Md Abdul Khalek; Christine Stabell Benn; Peter Aaby; Syed Manzoor Ahmed Hanifi
Journal:  EClinicalMedicine       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.